Macromolecule nanotherapeutics: approaches and challenges.
Sign Up to like & getrecommendations! Published in 2018 at "Drug discovery today"
DOI: 10.1016/j.drudis.2018.01.017
Abstract: With the advent of technology, newer forms of drugs, such as proteins, DNA, and RNA, have entered mainstream product development. However, systemic delivery of macromolecules is limited by rapid blood clearance, poor stability in vivo,… read more here.
Keywords: delivery; approaches challenges; macromolecule nanotherapeutics; nanotherapeutics approaches ... See more keywords
Nanotherapeutics approaches for targeting alpha synuclien protein in the management of Parkinson disease
Sign Up to like & getrecommendations! Published in 2021 at "Process Biochemistry"
DOI: 10.1016/j.procbio.2021.08.008
Abstract: Abstract Alpha synuclien (α-syn) is a protein consist of 140 amino-acid which is abundantly present in brain and associated with Parkinson diseases (PD). The physiological functions of α-syn are not clearly understood in neurochemistry. The… read more here.
Keywords: parkinson; nanotherapeutics approaches; syn; alpha synuclien ... See more keywords